Intended for healthcare professionals
Review

Acne vulgaris

Jonathan Cooke

B Pharm MPharm PhD FRPharmS Honorary Professor, Manchester Pharmacy School, University of Manchester

Acne vulgaris is a common skin disorder that affects most people at least once during their life. While its incidence peaks during the late teens, there are many adults that are affected – 12% of women and 3% of men over 25 years old.1

Acne vulgaris is not a fatal disease, but it can have significant psychosocial consequences, including diminished self-esteem, social withdrawal due to embarrassment, depression and unemployment. Optimal treatment is therefore important, especially as satisfactory results from treatment can be achieved in most cases.

Dermatology in practice 2018; 24(3): 68–70
To continue reading this article, please sign in or register.

Dermatology in practice was previously supported by Wyeth from 2008 to 2010, by Wyeth and Serono in 2007, by Wyeth and Shire from 2005 to 2006, by Medlock Medical in 2004 and by SSL International from 2001 to 2003.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the publisher, Editor or Editorial Board. Accordingly the publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Dermatology in practice is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2021 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 0262-5504 (Print) ISSN 2049-8446 (Online)